DNA methylation is a common molecular alteration in colorectal cancer cells and culture method has no influence on DNA methylation

Wang,Shibao; Huang,Yinghui; Mu,Xupeng; Qi,Tianyang; Qiao,Sha; Lu,Zhenxia; Li,Hongjun

doi:10.3892/etm.2018.5809

DNA methylation is a common molecular alteration in colorectal cancer cells and culture method has no influence on DNA methylation

Authors:
- Shibao Wang
- Yinghui Huang
- Xupeng Mu
- Tianyang Qi
- Sha Qiao
- Zhenxia Lu
- Hongjun Li
View Affiliations

Affiliations: Department of Oncology and Hematology, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China, Science Research Center, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China, Physical Examination Center, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: January 30, 2018 https://doi.org/10.3892/etm.2018.5809
Pages: 3173-3180
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore whether culture method had an influence on DNA methylation in colorectal cancer (CRC). In the present study, CRC cells were cultured in two‑dimensional (2D), three‑dimensional (3D) and mouse orthotopic transplantation (Tis) cultures. Principal component analysis (PCA) was used for global visualization of the three samples. A Venn diagram was applied for intersection and union analysis for different comparisons. The methylation condition of 5'‑C‑phosphate‑G‑3' (CpG) location was determined using unsupervised clustering analysis. Scatter plots and histograms of the mean β values between 3D vs. 2D, 3D vs. Tis and Tis vs. 2D were constructed. In order to explore the biological function of the genes, gene ontology and Kyoto Encyclopedia of Gene and Genomes (KEGG) pathway analyses were utilized. To explore the influence of culture condition on genes, quantitative methylation specific polymerase chain reaction (QMSP) was performed. The three samples connected with each other closely, as demonstrated by PCA. Venn diagram analysis indicated that some differential methylation positions were commonly shared in the three groups of samples and 16 CpG positions appeared hypermethylated in the three samples. The methylation patterns between the 3D and 2D cultures were more similar than those of 3D and Tis, and Tis and 2D. Results of gene ontology demonstrated that differentially expressed genes were involved in molecular function, cellular components and biological function. KEGG analysis indicated that genes were enriched in 13 pathways, of which four pathways were the most evident. These pathways were pathways in cancer, mitogen‑activated protein kinase signaling, axon guidance and insulin signaling. Furthermore, QMSP demonstrated that methylation of mutL homolog, phosphatase and tensin homolog, runt‑related transcription factor, Ras association family member, cadherin‑1, O‑6‑methylguanine‑DNA‑methyltransferase and P16 genes had no obvious difference in 2D, 3D and Tis culture conditions. In conclusion, the culture method had no influence on DNA methylation in CRC cells.

View Figures

View References

1	Lobert VH, Mouradov D and Heath JK: Focusing the spotlight on the zebrafish intestine to illuminate mechanisms of colorectal cancer. Adv Exp Med Biol. 916:411–437. 2016. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, Lasser P, Gayet B, Ruffié P and Grunenwald D: Surgery for lung metastases from colorectal cancer: Analysis of prognostic factors. J Clin Oncol. 14:2047–2053. 1996. View Article : Google Scholar : PubMed/NCBI
4	Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, D'Haens G, Pintér T, Lim R, Bodoky G, et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 360:1408–1417. 2009. View Article : Google Scholar : PubMed/NCBI
5	Jiang W, Wang PG, Zhan Y and Zhang D: Prognostic value of p16 promoter hypermethylation in colorectal cancer: A meta-analysis. Cancer Invest. 32:43–52. 2014. View Article : Google Scholar : PubMed/NCBI
6	Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, Gao F, Li DH, Zhao R, Feng GG and Yi J: Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res. 8:188–191. 2002.PubMed/NCBI
7	Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1:686–692. 1995. View Article : Google Scholar : PubMed/NCBI
8	Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, et al: MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 97:1330–1338. 2005. View Article : Google Scholar : PubMed/NCBI
9	Müller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Mühlthaler M, Ofner D, Margreiter R and Widschwendter M: Methylation changes in faecal DNA: A marker for colorectal cancer screening? Lancet. 363:1283–1285. 2004. View Article : Google Scholar : PubMed/NCBI
10	Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:pp. 9821–9826. 1996; View Article : Google Scholar : PubMed/NCBI
11	Deaton AM and Bird A: CpG islands and the regulation of transcription. Genes Dev. 25:1010–1022. 2011. View Article : Google Scholar : PubMed/NCBI
12	Costello JF, Frühwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P, Lang JC, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 24:132–138. 2000. View Article : Google Scholar : PubMed/NCBI
13	Holmquist GP and Ashley T: Chromosome organization and chromatin modification: Influence on genome function and evolution. Cytogenet Genome Res. 114:96–125. 2006. View Article : Google Scholar : PubMed/NCBI
14	Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science. 293:1068–1070. 2001. View Article : Google Scholar : PubMed/NCBI
15	Wistuba II, Mao L and Gazdar AF: Smoking molecular damage in bronchial epithelium. Oncogene. 21:7298–7306. 2002. View Article : Google Scholar : PubMed/NCBI
16	Chai H and Brown RE: Field effect in cancer-an update. Ann Clin Lab Sci. 39:331–337. 2009.PubMed/NCBI
17	Coppedè F, Migheli F, Lopomo A, Failli A, Legitimo A, Consolini R, Fontanini G, Sensi E, Servadio A, Seccia M, et al: Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: Correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism. Epigenetics. 9:621–633. 2014. View Article : Google Scholar : PubMed/NCBI
18	Godugu C and Singh M: AlgiMatrix™-based 3D cell culture system as an in vitro tumor model: An important tool in cancer research. Methods Mol Biol. 1379:117–128. 2016. View Article : Google Scholar : PubMed/NCBI
19	Hiler D, Chen X, Hazen J, Kupriyanov S, Carroll PA, Qu C, Xu B, Johnson D, Griffiths L, Frase S, et al: Quantification of retinogenesis in 3D cultures reveals epigenetic memory and higher efficiency in iPSCs derived from rod photoreceptors. Cell Stem Cell. 17:101–115. 2015. View Article : Google Scholar : PubMed/NCBI
20	Fidler IJ: The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 3:453–459. 2003. View Article : Google Scholar : PubMed/NCBI
21	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Bolstad BM, Irizarry RA, Åstrand M and Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
24	Ma CH, Lv Q, Cao Y, Wang Q, Zhou XK, Ye BW and Yi CQ: Genes relevant with osteoarthritis by comparison gene expression profiles of synovial membrane of osteoarthritis patients at different stages. Eur Rev Med Pharmacol Sci. 18:431–439. 2014.PubMed/NCBI
25	Bro R and Smilde AK: Principal component analysis. Anal Met. 6:2812–2831. 2014. View Article : Google Scholar
26	Rencher AC: Principal component analysis. Met Multi Anal (Second). 1–407. 2002.
27	Stambolic V, Suzuki A, De La Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998. View Article : Google Scholar : PubMed/NCBI
28	Blyth K, Cameron ER and Neil JC: The RUNX genes: Gain or loss of function in cancer. Nat Rev Cancer. 5:376–387. 2005. View Article : Google Scholar : PubMed/NCBI
29	Allen NP, Donninger H, Vos MD, Eckfeld K, Hesson L, Gordon L, Birrer MJ, Latif F and Clark GJ: RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene. 26:6203–6211. 2007. View Article : Google Scholar : PubMed/NCBI
30	Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW and Cuzick J: UK Flexible Sigmoidoscopy Trial Investigators: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet. 375:1624–1633. 2010. View Article : Google Scholar : PubMed/NCBI
31	Dai Z, Zheng RS, Zou XN, Zhang SW, Zeng HM, Li N and Chen WQ: Analysis and prediction of colorectal cancer incidence trend in China. Zhonghua Yu Fang Yi Xue Za Zhi. 46:598–603. 2012.(In Chinese). PubMed/NCBI
32	Ni S, Peng J, Huang D, Xu M, Wang L, Tan C, SUN H, Cai S and Sheng W: HER2 overexpression and amplification in patients with colorectal cancer: A large-scale retrospective study in Chinese population. Am Society Clin Oncol. 2017.
33	Mu WP, Wang J, Niu Q, Shi N and Lian HF: Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: A meta-analysis. Onco Targets Ther. 7:1237–1245. 2014. View Article : Google Scholar : PubMed/NCBI
34	Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, et al: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 38:787–793. 2006. View Article : Google Scholar : PubMed/NCBI
35	Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, et al: Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res. 63:4174–4180. 2003.PubMed/NCBI
36	Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al: The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 41:178–186. 2009. View Article : Google Scholar : PubMed/NCBI
37	Zhang JD and Wiemann S: KEGGgraph: A graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics. 25:1470–1471. 2009. View Article : Google Scholar : PubMed/NCBI
38	Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P and Ogier-Denis E: The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem. 276:35243–35246. 2001. View Article : Google Scholar : PubMed/NCBI
39	Perrone F, Lampis A, Orsenigo M, Di Bartolomeo M, Gevorgyan A, Losa M, Frattini M, Riva C, Andreola S, Bajetta E, et al: PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Ann Oncol. 20:84–90. 2009. View Article : Google Scholar : PubMed/NCBI
40	Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M and Takeyama H: Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol. 8:562008. View Article : Google Scholar : PubMed/NCBI
41	Miyazono K, Maeda S and Imamura T: Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene. 23:4232–4237. 2004. View Article : Google Scholar : PubMed/NCBI
42	Wai PY, Mi Z, Gao C, Guo H, Marroquin C and Kuo PC: Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem. 281:18973–18982. 2006. View Article : Google Scholar : PubMed/NCBI
43	Djos A, Martinsson T, Kogner P and Carén H: The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Mol Cancer. 11:402012. View Article : Google Scholar : PubMed/NCBI
44	van der Weyden L and Adams DJ: The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta. 1776:58–85. 2007.PubMed/NCBI
45	DesRochers TM, Shamis Y, Alt-Holland A, Kudo Y, Takata T, Wang G, Jackson-Grusby L and Garlick JA: The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics. 7:34–46. 2012. View Article : Google Scholar : PubMed/NCBI